SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Organovo Holdings, Inc. – ‘8-K’ for 2/8/12 – EX-4.7

On:  Monday, 2/13/12, at 5:13pm ET   ·   For:  2/8/12   ·   Accession #:  1213900-12-621   ·   File #:  333-169928

Previous ‘8-K’:  ‘8-K’ on 2/3/12 for 1/30/12   ·   Next:  ‘8-K’ on / for 2/14/12   ·   Latest:  ‘8-K’ on 4/23/24 for 4/19/24   ·   18 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 2/13/12  Organovo Holdings, Inc.           8-K:1,2,3,4 2/08/12   30:6.0M                                   Edgar Agents LLC/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML   1.17M 
 2: EX-2.1      Merger Agreement                                    HTML    647K 
 3: EX-2.2      Certificate of Merger                               HTML     24K 
 4: EX-4.1      Bridge Warrant                                      HTML     99K 
 5: EX-4.2      Bridge Note                                         HTML     58K 
 6: EX-4.3      Instrument Defining the Rights of Security Holders  HTML    157K 
 7: EX-4.4      Ppo Investor Warrant                                HTML    105K 
 8: EX-4.5      Exchange Warrant                                    HTML    140K 
 9: EX-4.6      Bridge Exchange Warrant                             HTML     97K 
10: EX-4.7      Form of Lock-Up                                     HTML     22K 
11: EX-10.1     Bridge Spa                                          HTML    102K 
13: EX-10.10    General Release Agreement                           HTML     27K 
14: EX-10.11    Share Cancellation Agreement                        HTML     19K 
15: EX-10.12    B Michaels Offer Lette                              HTML     24K 
16: EX-10.13    Presnell Offer Letter                               HTML     25K 
17: EX-10.14    2008 Equity Incentive Plan                          HTML    149K 
18: EX-10.15    2012 Equity Incentive Plan                          HTML    125K 
19: EX-10.16    Form of Stock Option Agreement                      HTML     59K 
20: EX-10.17    Indemnification Agreemeent                          HTML     74K 
21: EX-10.18    Baltera Mou                                         HTML     21K 
22: EX-10.19    Prestwich Sab Agreement                             HTML     51K 
23: EX-10.20    Mooney Sab Agreement                                HTML     58K 
24: EX-10.21    Vunjak-Novakovic Sab Agreement                      HTML     51K 
25: EX-10.22    Kent Sab Agreement                                  HTML     55K 
26: EX-10.23    License Agreement                                   HTML     80K 
27: EX-10.24    License Agreement                                   HTML     79K 
28: EX-10.25    License Agreement                                   HTML    233K 
12: EX-10.9     Split-Off Agreement                                 HTML    112K 
29: EX-16.1     Letter Re Change in Certifying Accountant           HTML     14K 
30: EX-21.1     Subsidiaries of Organovo Holdings, Inc.*            HTML      9K 


EX-4.7   —   Form of Lock-Up


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 4.7
 
LOCK-UP AGREEMENT


__________, 2012

Organovo Holdings, Inc.
5871 Oberlin Drive, Suite 150
San Diego, CA. 92121

Spencer Trask Ventures, Inc.
750 Third Avenue, 11th Floor
New York, NY 10017

Gentlemen:

Reference is made to the Agreement and Plan of Merger and Reorganization (the “Merger Agreement”), dated as of _____________, 2012, by and among Organovo Holdings, Inc., a Delaware corporation (the “Parent”), Organovo Acquisition Corp., a Delaware corporation, and Organovo, Inc., a Delaware corporation (the “Company”).  In connection with the Merger Agreement, stockholders of the Company shall receive shares of the Parent’s common stock, par value $0.001 per share (“Common Stock”), in consideration for shares of the Company held by them at the effective time of the merger.  In consideration of the Parent and the Company entering into the Merger Agreement, the undersigned, an officer, director or holder of 5% or more of the Company’s Common Stock, hereby agrees as follows:

1.           The undersigned hereby covenants and agrees, except as provided herein, during the Lockup Period (as defined below) not to (a) offer, sell, contract to sell, grant any option to purchase, hypothecate, pledge or otherwise dispose of or (b) transfer title to (a “Prohibited Sale”) any of the shares of Common Stock acquired by the undersigned pursuant to, and in connection with, the Merger Agreement (the “Acquired Shares”), in each case during the period commencing on the Closing Date (as defined in the Merger Agreement) and ending on the earlier of (i) twelve months from the Closing Date, or (ii) six months following the effective date of the Registration Statement (as defined in the Merger Agreement) (the “Lockup Period”), without the prior written consent of the Parent and Spencer Trask Ventures, Inc.  Notwithstanding the foregoing, the undersigned shall be permitted from time to time during the Lockup Period, without the prior written consent of the Parent and Spencer Trask Ventures, Inc., as applicable, (i) to engage in transactions in connection with the undersigned’s participation in the Parent’s stock option plans, if any, (ii) to transfer all or any part of the Acquired Shares to any family member, for estate planning purposes, or to an affiliate thereof (as such term is defined in Rule 405 under the Securities Act of 1933, as amended), provided that such transferee agrees in writing with the Parent to be bound hereby, or (iii) to participate in any transaction in which holders of Common Stock participate or have the opportunity to participate pro rata, including, without limitation, a merger, consolidation or binding share exchange involving the Parent, a disposition of the Common Stock in connection with the exercise of any rights, warrants or other securities distributed to the Parent’s stockholders, or a tender or exchange offer for the Common Stock, and no transaction contemplated by the foregoing clauses (i), (ii) or (iii) shall be deemed a Prohibited Sale for purposes of this Agreement.
 
 
 

 
 
2.           This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to principles of conflicts or choice of laws thereof.

3.           This Agreement will become a binding agreement among the undersigned as of the Closing Date (as defined in the Merger Agreement).  In the event that no closing occurs under the Merger Agreement, this Agreement shall be null and void.  This Agreement (and the agreements reflected herein) may be terminated by the mutual agreement of the Parent and the undersigned, and if not sooner terminated, will terminate upon the expiration date of the Lockup Period.  This Agreement may be duly executed by facsimile and in any number of counterparts, each of which shall be deemed an original, and all of which together shall be deemed to constitute one and the same instrument.  Signature pages from separate identical counterparts may be combined with the same effect as if the parties signing such signature page had signed the same counterpart.  This Agreement may be modified or waived only by a separate writing signed by each of the parties hereto expressly so modifying or waiving such agreement.

4.           This Lock-Up Agreement constitutes the entire agreement between the parties with regard to the lock up restriction and supersedes any prior understandings, agreements, or representations by or between the parties.

 
  Very truly yours,  
     
     
  Print Name:  
     
     

Address:                                                                                     
                                                                                     
Number of shares of Common Stock owned:                                                                
Certificate Numbers:                                                                                     

[Company and STVI signatures on the following page]
 
 
 

 

Accepted and Agreed to:

Organovo Holdings, Inc.
 
     
By:
   
Name: Keith Murphy  
Title: Chief Executive Officer  
     
 
                         
Spencer Trask Ventures, Inc.
 
     
By:
   
Name: John Heidenreich  
Title: President  
     
 
 

18 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/12/24  Organovo Holdings, Inc.           S-1                   76:11M                                    Donnelley … Solutions/FA
 7/31/23  Organovo Holdings, Inc.           10-K/A      3/31/23   12:1.4M                                   Donnelley … Solutions/FA
 7/14/23  Organovo Holdings, Inc.           10-K        3/31/23   75:12M                                    Donnelley … Solutions/FA
10/25/22  Organovo Holdings, Inc.           S-8 POS    10/25/22    3:103K                                   Donnelley … Solutions/FA
10/25/22  Organovo Holdings, Inc.           S-8 POS    10/25/22    3:103K                                   Donnelley … Solutions/FA
10/25/22  Organovo Holdings, Inc.           S-8 POS    10/25/22    3:103K                                   Donnelley … Solutions/FA
10/25/22  Organovo Holdings, Inc.           S-8 POS    10/25/22    3:103K                                   Donnelley … Solutions/FA
10/25/22  Organovo Holdings, Inc.           S-8 POS    10/25/22    3:103K                                   Donnelley … Solutions/FA
 6/10/22  Organovo Holdings, Inc.           10-K        3/31/22   76:8.3M                                   ActiveDisclosure/FA
11/09/21  Organovo Holdings, Inc.           S-8        11/09/21    3:88K                                    Donnelley … Solutions/FA
 7/29/21  Organovo Holdings, Inc.           10-K/A      3/31/21   12:1.3M                                   ActiveDisclosure/FA
 6/15/21  Organovo Holdings, Inc.           10-K        3/31/21   74:7.1M                                   ActiveDisclosure/FA
 9/17/20  Organovo Holdings, Inc.           8-K:5,9     9/15/20    1:127K                                   ActiveDisclosure/FA
 9/03/20  Organovo Holdings, Inc.           DEFA14A     9/03/20    1:120K                                   ActiveDisclosure/FA
 9/03/20  Organovo Holdings, Inc.           8-K:3,5,9   9/02/20    2:85K                                    ActiveDisclosure/FA
 6/21/12  SEC                               UPLOAD10/03/17    1:45K  Organovo Holdings, Inc.
 4/18/12  SEC                               UPLOAD10/03/17    1:55K  Organovo Holdings, Inc.
 3/13/12  SEC                               UPLOAD10/03/17    1:61K  Organovo Holdings, Inc.
Top
Filing Submission 0001213900-12-000621   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 11:32:32.3pm ET